Professor Kenneth Kwing-Chin LEE


Professor of Pharmacy
School of Pharmacy
+603 5514 5604
Room  2-5-33

Professor Lee obtained his undergraduate degree in pharmacy from the University of Washington in Seattle, USA, and his subsequent higher qualifications from the Chinese University of Hong Kong (CUHK) and the University of Oxford, UK.

He is widely recognized as one of the pioneers in pharmacoeconomics and outcomes research in Asia, and was the founding president of the Hong Kong Chapter of the International Society for Pharmacoeconomics and Outcomes Research that was established in 1999. Prof Lee was Professor and Associate Director of External Affairs of the Chinese University of Hong Kong’s School of Pharmacy of which he was a founding member before he moved to Malaysia.

His concurrent academic appointments include Adjunct Professor of the CUHK School of Pharmacy, Honorary Professor of the Li Ka Shing Faculty of Medicine of the University of Hong Kong, and Visiting Professor of the University of London School of Pharmacy, UK (2008-2011). Professor Lee has also maintained very close links with academic institutions in Mainland China for many years and has served as visiting scholar at a number of universities there.

He was appointed by the Government of Hong Kong as a Justice of the Peace in 2003 for his outstanding community services. He has published extensively in international peer-reviewed journals. He has been Editor-in-Chief of Journal of Medical Economics (UK) since 2006 and recently appointed as Co-Editor of Value in Health Regional Issue (US).


-  Advanced Certificate in Health Economics, University of Oxford, 2006

-  Doctor Of Philosophy, The Chinese University Of Hong Kong, 1999

-  Master of Philosophy, The Chinese University Of Hong Kong, 1991

-  Bachelor of Pharmacy, University of Washington, 1978

Research Experience and Employment

  • Jan 2015 - Current Professor of School of Pharmacy, School of Pharmacy, Monash University Malaysia
  • Aug 2010 - Dec 2014 Professor of Pharmacy and Head, School of Pharmacy, Monash University Malaysia
  • Sept 2006 - Jul 2010 Associate Director, External Affairs, The Chinese University of Hong Kong (CUHK)
  • May 2002 - Aug 2006 Professor, School of Pharmacy, CUHK
  • July 1996 - Jun 1997 Associate Professor, School of Pharmacy, CUHK
  • Jul  1992 - Jun 1996 Lecturer, School of Pharmacy, CUHK
  • Apr 1986 - Jul 1992 Senior Lecturer, Vocational Training Council, Hong Kong
  • Sept 1978 - Mar 1986 Director of Pharmacy, Service, Tsuen Wan Adventist Hospital, Hong Kong

Health economics/pharmacoeconomics - measurement and valuation of health, including preference-based generic instruments and discrete choice experiments as well as the analysis of patient level data and decision-analytic modelling. Professor Kenneth also focusses on a critical examination of the validity of such evaluations in the global context generally and in emerging economies in particular. While continuing to contribute to and promote model investigations into the cost-efficiency and outcomes of new interventions, his research is now increasingly moving towards robust large studies that will offer planners and policy makers a far less speculative lever for making important broad decisions on health care.

Peer- Reviewed Journal

Wu DBC, Yee CH, Ng ACF, Lee SWH, Chaikunapruk N, Lee KKC. Economic evaluation of combination therapy versus monotherapy for treatment benign prostatic hyperplasia in Hong Kong. Frontiers in Pharmacol

Choon JWY, Wu DBC, Ching HY, Lo WTL, Chong CSY, Chung WS, Chui EMC, Tomlinson B, Lee VWY, Lee SC, Lee KKC. Real-world evidence of improved healthcare utlization in patients with schizophrenia or schizoaffective disorder after eaerly treatment of paliperidone palmitate once-monthly treeatment in Hong Kong

Lee JY, Chan CKY, Chua SS, Ng CJ, Paraidathathu T, Lee KKC, Wong CP, Tan CSS, Nasir NH, Lee SWH. Is telemedicinethe answer for type 2 diabetes mellitus management: a patient’s perspective. Diab T

Andiesta NS, Tan BS, Mamid M, KKC Lee, Pau A. Study protocol of cost effectiveness analysis on randomized control trial of dental home visits (DHVs) in caries prevention among preschool children. JMIR Research Protocols

Jun Y. Lee, C. K.Y. Chan, Siew S. Chua, Chirk J. Ng, Thomas Paraidathathu, KKC Lee, Shaun W.H. Lee. Telemonitoring and Team-based Management of Glycemic Control in Type 2 Diabetes Mellitus Patients: A Cluster Randomized Controlled trial. BMJ

Wu DBC, Chaiyakunapruk N, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Smith PF, Kirkpatrick C, Kamal MA, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Rayner CR. Cost-utility analysis of antiviral use under pandemic influenza using a novel approach – linking pharmacology, epidemiology and health economics, Epidemiology and Infection

MA Kamal, PF Smith, N Chaiyakunapruk, DBC Wu, C Pratoomsoot, KKC Lee, HY Chong, RE Nelson, K Nieforth, G Dall, S Toovey, DCM Kong, A Kamauu, CM Kirkpatrick and CR Rayner, Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology, and Health Economics to Inform Antiviral Use in Pandemics, British Journal of Clinical Pharmacology

Wu, DB, Lee, KKC Lee, VWY, Hong, LW. Reply to Varghese et al.'s response to Wu et al.- Cost effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong - Human Vaccines and Immunotherapeutics (Volume 12,Issue 10,2 Oct 2016, Pages 2681-2684) DOI:10.1080/21645515.2016.1209279

Jun Yang Lee, Carina Ka Yee Chan, Siew Siang Chua, Chirk Jenn Ng, Thomas Paraidathathu, KKC Lee, Shaun Wen Huey Lee. Intervention for Diabetes with Education, Advancement and Support (IDEAS) study: Protocol for a cluster randomised controlled trial - BMC Health Services Research (Volume16, Issue1, 29 Sept 2016) Article number 1782 DOI: 10.1186/s12913-016-1782-y

Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong - Human Vaccines and Immunotherapeutics (Volume 12,Issue 2,1 Feb 2016,Pages403-416) DOI: 10.1080/21645515.2015.1067351

Wu DBC, Roberts C, Lee VWY, Hong LW, Lee KKC. Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong. Human Vaccines and Immunotherapeutics (2015) DOI:10.1080/21645515.2015.1067351

Wu DB, S.Hussain, Mak V, KKC Lee. Cost-Effectiveness Analysis of Strontium Ranelate Verse Alendronate for Management of Osteoporosis Among Post-Menopausal Women in Malaysia Using A Markov Modelling Approach ARTICLE in VALUE IN HEALTH 17(7):A382 · NOVEMBER 2014 (DOI: 10.1016/j.jval.2014.08.2625)

Wu DB, Chayanin Pratoomsoot, Chaiyakunapruk N, Lee KKC, H.Y. Chong, R.E.Nelson. Cost-Utility Analysis of Optimal Dosing of Oseltamivir Under Pandemic Influenza Using a Novel Approach: Linking Health Economics and Transmission Dynamic Models. Value in Health. 11/2014; 17(7):A807. DOI: 10.1016/j.jval.2014.08.527

Wu DB, Yee CH, Ng ACF, Chaiyakunapruk N, Lee KKC. Health and economic impact of combination therapy vs. Monotherapy for treatment of benign prostatic hyperplasia in Hong Kong. (ARTICLE in VALUE IN HEALTH 17(7):A812 · NOVEMBER 2014  DOI: 10.1016/j.jval.2014.08.558)

Smith PF, Kirkpatrick C, Rayner CR, Nieforth K, Dall G, Toovey S, Kong DCM, Wu DB, Chaiyakunapruk N, Lee KKC, Pratoomsoot C, Yi CH, Kamauu A, Nelson R, Kamal MA. Estimating Health Outcomes of Antiviral Use in Influenza (flu) Outbreaks by Linking PK/PD and Epidemiology via Transmission Dynamic Model: A Novel Approach (Conference: IDWeek 2014 Meeting of the Infectious Diseases Society of America)  DOI: 10.1093/ofid/ofu052.771

Wu DB, H.Y. Chong, KKC Lee.  Cost-Effectiveness Analysis Of Joint Vaccination With 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) And Influenza Vaccine In Taiwan During Seasonal Influenza Value in Health. 05/2014; 17(3):A273. DOI:

Wu DBC, Chaiyakunapruk N, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Smith PF, Kirkpatrick C, Kamal MA, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Rayner C. Cost-Utility Analysis of Optimal Dosing of Oseltamivir Under Pandemic Influenza Using a Novel Approach: Linking Health Economics and Transmission Dynamic Models (Value in Health 17(7):A807) DOI: 10.1016/j.jval.2014.08.527

BM Yang, KKC Lee, Chaiyakunapruk N, Guo J. A year of significant progress in value in health regional issue (Editorial). Value In Health Regional Issues 3C, 2014:172-173

Lee KKC, Wu DBC, Mak V, Lee SC, Siew P. Economic evaluation of ticagrelor in treating patients with acute coronary syndrome in Hong Kong: a cost-utility analysis. Hong Kong Medical Journal 2013 (journal ISSN :1098-3015  DOI10.1016/j.jval.2013.03.1500)

Lee KKC, Pashos CL. Working towards best practice in communicating health economics research (Commentary) J Med Econ Vol 16 (3), 2013:1-2

Lee KKC, Wu DBC. Health Care Cost Avoidance Due to Insulin Glargine for Type 2 Diabetic Patients in Hong Kong as Compared to NPH Insulin. Value in Health. 11/2013; 16(7). DOI: 10.1016/j.jval.2013.08.735

KKC Lee, DBC Wu, O Topachevskyi, E Delgleize, R DeAntonio. The Health Economic Impact of Universal Infant Vaccination with the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as Compared with 13-Valent Pneumococcal Conjugate Vaccine in Hong Kong. Value In Health Regional Issues 2013; 2(1); 64-74

Wu DBC, Ho EHM, Chung WS, Chow DPY, Lee VWY, Wong MC, Lee KKC. Cost Analysis of Long-Lasting Risperidone Injection in the Treatment of Schizophrenia and Schizoaffective Disorders in Hong Kong: An Approach Using Generalized Estimating Equations. Psychiatry Research 210,2013:745-750

Lee KKC. Editorial for Special Issue on Cost-Effectiveness Analyses, J Med Econ Vol. 15, Supplement S1, 2012, 1–2  (Dec 2012)

Luk LM, Hon E, Lee KKC, Lee VWY. Efficacy and safety of diphenyl-cyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata. J European Academy of Dermatology & Venereology. Sept 2012

Coulton L,  Annemans L, Carter R, Herrera MB, Hasbullah T, Lim J, Lee KKC, Chen W, Chaiyakunapruk N, Chern HD, Lee TJ, Nakamura H, Tarn TYH, Keskinaslan A. Outcomes-based Risk-sharing Schemes: Is There a Potential Role in the Asia-Pacific Markets? Health Outcomes Research in Medicine 2012 (available online 16 July 2012).

Hon KL, Wang SS, Lee KKC, Lee VWY, Leung TF, Ip, M. Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema: Friend or foe. J Drugs in Dermatology. 2012;11(7):861-4

Book Chapter

Rinaldi F, Lee KKC, Wu DBS, Huang YC, Chang CJ, Chong CY. “Economic Impact of Routine 7-Valent Pneumococcal Conjugate Vaccine in the Asia-Pacific: Lessons Learned from Hong Kong, Singapore, and Taiwan”, ISPOR Research Digest Aug 2009

Lee Kwing Chin. “Methods and design of pharmacoeconomics studies” Chapter 6, Pharmacoeconomics. Fudan University, Shanghai, China. Higher Education Press, July 2009; 106-110

Lee KKC. Pharmacology of MDMA, ketamine and methamphetamine (Ice), common poly-substance abuse resource book for seminar for doctors to help beat drugs. 2002, pp.24-26, Hong Kong Medical Association

Principle Investigator by International Health Organisations and Pharmaceutical Companies

Pfizer Global – Efficiency Drivers and Barriers Research – USD40,000, April 2018

Servier Malaysia – Diamicron cost impact study – RM75,000, May 2018

Sanofi, Malaysia – Alemtuzumab HEOR study – RM67,000, Mar 2018

Johnson & Johnson Hong Kong – An initial estimation of potential savings for schizophrenic patients receiving paliperidone palmitate 3-monthly injection in the public sector of Hong Kong – (HK80,000) 2017

AstrraZeneca Sdn Bhd - Dapagliflozin budget impact analysis model and final budget impact analysis report (RM46,948)

Daichii Hong Kong - Cost-effectiveness of edoxaban in patients with non-valvular atrial fibrillation in Hong Kong (HK150,000), 2016

Novartis Malaysia – Budget impact analysis of secukinumab in psoriatic arthritis and ankylosing spondylitis in the public sector of Malaysia – (MYR120,000), 2016

WHO (Geneva, Switzerland) - An economic evaluation of tuberculosis diagnosis algorithms in Malaysia: an approach using dynamic transmission model” from World Health Organization – (MYR 66,855) 2015

AstraZeneca Hong Kong Limited - The Analysis and Publication of Health Economics Data for Dapagliflozin in Hong Kong (HKD260K), 2015

D3/ Roche/ Monash - Linking Pharmacology to Pharmacoeconomics by extending Roche’s Tamiflu Dose Prediction Program (MYR168,180), 2015

Janssen Hong Kong - Health Care Resource Utilization Analysis of Paliperidone Palmitate In The Treatment Of Schizophrenia In The Public Health Care Sector of Hong Kong (HKD250K), 2015

Postgraduate (MSc and PhD)

Subramaniam Thanimalai (PhD: Sept 2018-present) 
Economic evaluation of oral anti-cancer medication in the neoadjuvant treatment of women with her-2 positive breast cancer
- Main Supervisor

Niekla S Andiesta (PhD: _________) 
Cost Effectiveness Analysis comparing six monthly dental home visits and educational leaflets in caries prevention among preschool children
- Co-supervisor

Muhammad Hafeezul Suraj Anthony Wilson (MSc - Completed)  
Pharmacoeconomics analysis for the early use of insulin in T2DM patients in Malaysia
- Main Supervisor

Fun Weng Hong (PhD- Completed)  
Health and economic impact of Tuberculosis management in Malaysia
- Main Supervisor

Kenny CF Kuok (MPhil - Completed)  
Cost effectiveness study of multiple myeloma regimens in Macau
- Main Supervisor

Nelson LC Lam (MPhil - Completed)  
Cost of coronary heart disease management in a public hospital setting in Hong Kong
- Main Supervisor

Bonny SW Chan (MPhil - Completed)  
Cost of type 2 diabetes mellitus in Hong Kong Chinese and economic analysis of a new antidiabetic agent
- Main Supervisor

Joyce TS Ho (MPhil - Completed)  
The impact of selective COX-2 inhibitor on the cost of NSAID-induced gastrointestinal toxicity in a public hospital setting in Hong Kong
- Main Supervisor

Lo Shwu-chun (MPhil - Completed)  
Metabolic effects of rosiglitazone and orlistat on insulin action in a group of Chinese patients with impaired glucose tolerance or type 2 diabetes mellitus
- Main Supervisor

Chu Kevin KW (PhD - Completed)  
Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from Coriolus versicolor
- Main Supervisor

Membership in International/National Bodies

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Avedis Donabedian Lifetime Achievement Award Committee (LAAC)
- 2106-2020
- Member

ISPOR Asia Consortium Executive Committee member
- ISPOR 7th Asia-Pacific Conference Sep 2016
- Co-Chair of the Research Review Committee

International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
- Board of Directors
- Jun 2012 -Jun 2014

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ASIA CONSORTIUM
- Chair, Publication Committee
- Sept 2010 - 2012

Ministry of Health Technical Advisory Committee for Health Technologies Economic Evaluation (TACHTEE)
- Member
- 2015-2016

Ministry of Health Malaysia, Pharmaceutical Services Division: D-Setara (Discipline-Based Rating System) in the fields of Medicine, Dentistry and Pharmacy
- Member
- 2011-2013

Ministry of Health Malaysia : Pharmacoeconomics Technical Committee
- Chief Advisor
- 2011-2012

Membership in Academic Editorial Committees

Value In Health Regional Issue US
- Co-Editor
- Current

Journal of Medical Economics UK
- Editor-In-Chief
- 2006-Current